Author

Gary Joseph Doherty

Cambridge University Hospitals NHS Foundation TrustORCID 0000-0002-8158-8111Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Research Focus:variant calling· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

A.R. Phillips· 1 shared Aditi VediiD· 1 shared Alex CaganiD· 1 shared Alice T. Browne· 1 shared Alyson SpeediD· 1 shared Anna Clay· 1 shared Anna SantarsieriiD· 1 shared Carla P. MartinsiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A.R. Phillips

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintMay 9, 2026

Mutant KRAS dosage contributes to heterogeneity in lung cancer therapeutic response

Alice T. Browne, Chris McCann, William J. McDaid…·Emma M. Kerr

This study shows that mutant KRAS dosage affects therapeutic response in lung cancer, with higher dosages linked to resistance to platinum therapy and sensitivity to pS6K inhibition.

DOI 10.64898/2026.05.06.723208

humanbulk RNA-seq

𝕏 PostBluesky

Cell BiologyNature GeneticsPeer-reviewedJul 1, 2025

The long-term effects of chemotherapy on normal blood cells

Emily Mitchell, My H. Pham, Anna Clay…·Michael R. Stratton

This study examines the long-term effects of chemotherapy on normal blood cells by analyzing mutation burdens and cell population structure in treated individuals.

52 citationstop 1%

humanwhole-exome sequencing

𝕏 PostBluesky